New York Life Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-183
Closed -$13K 282
2016
Q1
$13K Sell
183
-233
-56% -$17.6K 0.06% 213
2015
Q4
$35K Sell
416
-543
-57% -$45.1K 0.15% 160
2015
Q3
$80K Buy
959
+610
+175% +$51.5K 0.36% 111
2015
Q2
$29K Sell
349
-615
-64% -$46.9K 0.12% 168
2015
Q1
$70K Sell
964
-1,159
-55% -$82.5K 0.28% 125
2014
Q4
$146K Sell
2,123
-885
-29% -$59.7K 0.58% 58
2014
Q3
$195K Sell
3,008
-24
-0.8% -$1.52K 0.81% 31
2014
Q2
$188K Hold
3,032
0.79% 35
2014
Q1
$178K Sell
3,032
-137
-4% -$7.65K 0.79% 32
2013
Q4
$162K Buy
3,169
+2,216
+233% +$111K 0.74% 36
2013
Q3
$48K Sell
953
-183
-16% -$9.58K 0.24% 143
2013
Q2
$56K Buy
+1,136
New +$61.8K 0.26% 125

Other funds holding LLY

New York Life Trust's LLY Position: Q2 2016 in Review

New York Life Trust sold out of Eli Lilly (LLY) in Q2 2016, closing a stake of 183 shares — an estimated $13K sold.

New York Life Trust first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $195K in Q3 2014. 1,179 funds tracked by Wall St. Rank hold LLY as of Q2 2016.

  • New York Life Trust reported no remaining Eli Lilly position as of Q2 2016 after selling out during the quarter.
  • New York Life Trust sold 183 Eli Lilly shares in Q2 2016, an estimated $13K.
  • New York Life Trust first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • New York Life Trust's Eli Lilly position peaked at $195K in Q3 2014.
  • 1,179 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2016.

Based on New York Life Trust's 13F filing for Q2 2016, filed 15 Aug 2016.